“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not bring about tolerance with Serious use,” claims Stahl, a senior team scientist within the Bohn lab. “This can be a desirable aspect for probable use while in the context of chronic, intense suffering.”“We display that these compounds bind to anoth